// App-Quantinova.ai

MA05.03 : Considering the Continued Impact of the COVID-19 Pandemic on Patient Advocacy and Support Organisations

Researchers

Presenter

  • M. Peters

Principal Investigators

  • J. Fox

  • R. Thakrar

Medical Centers

  • Cancer Care, New York/NY/US

  • Incisive Health, London/GB

  • Prevent Cancer Foundation, Virginia/VA/US

  • Respirando Con Valor, Mexico City/MX

  • Irish Cancer Society, Dublin/IE

  • Roy Castle Lung Cancer Foundation, Liverpool/GB

  • Respiratory Medicine, Concord Hospital, Sydney/NSW/AU

  • Go2 Foundation, Washington Dc/WA/US

Locations

  • United States

  • United Kingdom

  • South Africa

  • Mexico

  • Canada

  • Ghana

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Coronavirus disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A